HERVAXIN Trademark

Trademark Overview

On Tuesday, August 13, 2013, a trademark application was filed for HERVAXIN with the United States Patent and Trademark Office. The USPTO has given the HERVAXIN trademark a serial number of 79137604. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, August 12, 2023. The HERVAXIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products namely vaccine against cancer
hervaxin

General Information

Serial Number79137604
Word MarkHERVAXIN
Filing DateTuesday, August 13, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, August 12, 2023
Registration Number4500099
Registration DateTuesday, March 25, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements

Goods and ServicesPharmaceutical products namely vaccine against cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

NOT AVAILABLE

Trademark Events

Event DateEvent Description
Sunday, March 10, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, March 10, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, July 22, 2022NEW REPRESENTATIVE AT IB RECEIVED
Sunday, April 10, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, March 7, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, March 7, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Friday, July 4, 2014NOTIFICATION PROCESSED BY IB
Monday, June 16, 2014FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 16, 2014FINAL DISPOSITION PROCESSED
Thursday, April 24, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, March 25, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Monday, January 6, 2014NOTIFICATION PROCESSED BY IB
Wednesday, December 18, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 18, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 18, 2013NOTICE OF PUBLICATION
Sunday, December 1, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 30, 2013ASSIGNED TO EXAMINER
Friday, November 1, 2013APPLICATION FILING RECEIPT MAILED
Monday, October 28, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 25, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

hervaxin against cancer vaccine namely products pharmaceutical